Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

November 2016 - FRMC

Department

Managed Care Q&A
12/09/2016

By Dean Celia

By Dean Celia
Margaret E O’Kane continues the discussion on the evolution of quality care, including challenges that have been overcome and those that remain.
Margaret E O’Kane continues the discussion on the evolution of quality care, including challenges that have been overcome and those that remain.
Margaret E O’Kane continues the...
12/09/2016
First Report Managed Care
News Connection
11/27/2016
The future of the 21st Century Cure Act, which includes funds for medical research and aims to speed up the FDA's drug approval process, is up in the air following a recent push from patient advocacy and union groups to hold the bill until...
The future of the 21st Century Cure Act, which includes funds for medical research and aims to speed up the FDA's drug approval process, is up in the air following a recent push from patient advocacy and union groups to hold the bill until...
The future of the 21st Century...
11/27/2016
First Report Managed Care
Managed Care Q&A
11/22/2016

By David Costill

By David Costill
An interview with Albert Tzeel, MD, regional medical director, Humana
An interview with Albert Tzeel, MD, regional medical director, Humana
An interview with Albert Tzeel,...
11/22/2016
First Report Managed Care
News Connection
11/22/2016
Treatment with the investigational biologic ibalizumab (TaiMed Biologics/Theratechnologies) appeared to safely reduce the viral loads of patients with multidrug-resistant HIV, according to late-breaking phase III trial results recently...
Treatment with the investigational biologic ibalizumab (TaiMed Biologics/Theratechnologies) appeared to safely reduce the viral loads of patients with multidrug-resistant HIV, according to late-breaking phase III trial results recently...
Treatment with the...
11/22/2016
First Report Managed Care
News Connection
11/22/2016
A pair of identically designed phase 3 trials found that Dupixent (dupilumab; Sanofi/Regeneron) improved symptoms of moderate-to-severe atopic dermatitis, including itching, anxiety and depression, and quality of life, compared with placebo.
A pair of identically designed phase 3 trials found that Dupixent (dupilumab; Sanofi/Regeneron) improved symptoms of moderate-to-severe atopic dermatitis, including itching, anxiety and depression, and quality of life, compared with placebo.
A pair of identically designed...
11/22/2016
First Report Managed Care
News Connection
11/22/2016
Women who took Lynparza (olaparib; AstraZeneca) tablets as a monotherapy for maintenance treatment of platinum-sensitive relapsed BRCA-mutated ovarian cancer showed significantly improved progression-free survival compared with women who took...
Women who took Lynparza (olaparib; AstraZeneca) tablets as a monotherapy for maintenance treatment of platinum-sensitive relapsed BRCA-mutated ovarian cancer showed significantly improved progression-free survival compared with women who took...
Women who took Lynparza...
11/22/2016
First Report Managed Care
News Connection
11/22/2016
A recently study suggests amyloid positron emission tomography alongside routine cognitive impairment assessment may improve physicians’ diagnosis and management of Alzheimer disease.
A recently study suggests amyloid positron emission tomography alongside routine cognitive impairment assessment may improve physicians’ diagnosis and management of Alzheimer disease.
A recently study suggests...
11/22/2016
First Report Managed Care
News Connection
11/22/2016
Recent data show higher medical adherence by patients who use mail-order pharmacies compared to those who use retail pharmacies, although more research is still needed.
Recent data show higher medical adherence by patients who use mail-order pharmacies compared to those who use retail pharmacies, although more research is still needed.
Recent data show higher medical...
11/22/2016
First Report Managed Care
News Connection
11/22/2016
Results of a new study suggest that patient-centered medical homes (PCMHs) have diverse effects on different outcomes for diabetes care.
Results of a new study suggest that patient-centered medical homes (PCMHs) have diverse effects on different outcomes for diabetes care.
Results of a new study suggest...
11/22/2016
First Report Managed Care
News Connection
11/22/2016
In a recent letter, a group of physician, consumer, and employment groups urged President Obama to waive agreements that would lengthen data protections for biologic medicines in an expansive Asia-Pacific trade deal.
In a recent letter, a group of physician, consumer, and employment groups urged President Obama to waive agreements that would lengthen data protections for biologic medicines in an expansive Asia-Pacific trade deal.
In a recent letter, a group of...
11/22/2016
First Report Managed Care

Advertisement

Advertisement

Advertisement